3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Colonic Neoplasms
4
Rectal Neoplasms
3
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Surgical Wound Infection
1
Stomatitis
1
Sigmoid Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Melanoma
1
Lung Injury
1
Ileus
1
Hidrocystoma
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Febrile Neutropenia
1
Fatigue
1
Esophageal Atresia
1
Endometrial Neoplasms
1
Interventions
Oxaliplatin
10
Gemcitabine
8
Cisplatin
7
Hepatectomy
6
Fluorouracil
6
Radiofrequency Ablation
5
Liver Transplantation
5
Irinotecan
5
Capecitabine
5
lenvatinib
4
Paclitaxel
4
Neoadjuvant Therapy
4
Folfox protocol
4
Cetuximab
4
Aspirin
4
tislelizumab
3
Surgical Procedures, Operative
3
Nivolumab
3
Carboplatin
3
titanium silicide
2
durvalumab
2
apatinib
2
Trastuzumab
2
S 1 (combination)
2
Leucovorin
2
Lamivudine
2
Introns
2
Ethiodized Oil
2
Drug Therapy
2
DNA, Mitochondrial
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Sodium Chloride
×
Gastrointestinal
×
Clear all
NCT05250791
2023-06-09
FLICOR
Imperial College London
Phase NA
Unknown
50 enrolled